Fungal meningitis historical perspective: Difference between revisions

	Meningitis main page
	Fungal meningitis Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fungal meningitis from other Diseases
Epidemiology and Demographics
Screening
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X-ray
ECG
MRI
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Findings
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Case Studies
Case #1
Fungal meningitis historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Fungal meningitis historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Fungal meningitis historical perspective
CDC on Fungal meningitis historical perspective
Fungal meningitis historical perspective in the news
Blogs on Fungal meningitis historical perspective
Directions to Hospitals Treating Fungal meningitis
Risk calculators and risk factors for Fungal meningitis historical perspective

Revision as of 18:39, 2 February 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

The major advancements in the history of meningitis may be summarized as follows:^[1]

C. neoformans, an encapsulated basidiomycetous yeast, represents one of the most common CNS pathogens encountered in clinical practice today.
The first report of human cryptococcosis was published by Busse and Busckhe more than 100 years ago; 10 years later, it was identified as the cause of human meningitis.

In 1661, Thomas Willis first described the inflammation of meninges and an epidemic of meningitis.
In 1891, Heinrich Quincke provided an early analysis of CSF by introducing a new technique of lumbar puncture.
In early 19th century, detailed profile of CSF analysis in meningitis was explained by William Mestrezat, and H. Houston Merritt.
Advancements regarding the treatment of bacterial meningitis was given by Georg Joachmann in Germany and Simon Flexnor in USA in 18th and 19th century respectively

@@ Line 5: / Line 5: @@
 ==Historical perspective==
-C. neoformans, an encapsulated basidiomycetous yeast, represents one of the most common CNS pathogens encountered in clinical practice today. The first report of human cryptococcosis was published more than 100 years ago by Busse and Busckhe; approximately a decade later, it was identified as the cause of human meningitis.
 The major advancements in the history of meningitis may be summarized as follows:<ref name="pmid19892131">{{cite journal| author=Tyler KL| title=Chapter 28: a history of bacterial meningitis. | journal=Handb Clin Neurol | year= 2010 | volume= 95 | issue=  | pages= 417-33 | pmid=19892131 | doi=10.1016/S0072-9752(08)02128-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19892131  }} </ref>
+* C. neoformans, an encapsulated basidiomycetous yeast, represents one of the most common CNS pathogens encountered in clinical practice today.
+* The first report of human cryptococcosis was published by Busse and Busckhe more than 100 years ago; 10 years later, it was identified as the cause of human meningitis.
 *In 1661, Thomas Willis first described the [[inflammation]] of [[meninges]] and an [[epidemic]] of meningitis.